Paediatric anaesthesia in France: National data on outpatient procedures, emergency admissions, and critical outcomes

Karine Nouette-Gaulain1, Aurélie San Miguel2, Michele Brami3

  • 1Univ. Bordeaux, INSERM U12-11, Laboratoire de Maladies Rares: Génétique et Métabolisme (MRGM), 176 Rue Léo Saignat, F-33000 Bordeaux, France; CHU Bordeaux, Service d'Anesthésie Réanimation Femme Mere Enfant, Hôpital Pellegrin, Place Amélie Raba Léon, F-33000 Bordeaux, France; Board of French Association of Ambulatory Surgery.

Insights

Outpatient pediatric anesthesia in France reached 76.2% in 2023. Analysis revealed variations in care based on hospital type and patient age, highlighting the need for personalized healthcare strategies.

Area of Science:

  • Pediatric Anesthesiology
  • Healthcare Management
  • Public Health Policy

Background:

  • France aims for 80% outpatient pediatric anesthesia.
  • Current rates vary significantly across institutions.
  • Variations stem from organizational, patient, and admission factors.

Purpose of the Study:

  • Analyze factors influencing outpatient pediatric anesthesia rates.
  • Identify barriers to outpatient care feasibility.
  • Compare outpatient rates between public and private hospitals.

Main Methods:

  • Utilized French national PMSI database for 2023 anesthesia cases.
  • Collected data on institution type, length of stay, procedure, admission status, ICU stay, mortality, age, and gender.
  • Included both ambulatory and non-ambulatory cases.

Main Results:

  • Performed 990,296 anesthesia procedures for 704,796 children (0-17 years).
  • Overall outpatient rate was 76.2%.
  • Private hospitals had >90% outpatient rates; public hospitals had 58.8% outpatient rates. Infants under one year showed significant differences in outpatient rates between public (22.8%) and private (72.7%) hospitals.

Conclusions:

  • Personalized healthcare pathways are crucial.
  • Strengthening local/regional healthcare organization is key.
  • Focusing on patient characteristics and needs is more effective than solely increasing outpatient rates.
Abstract

Related Concept Videos

Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
687
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
602
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.0K